Two independent studies from University of Southern Denmark confirm that patients with type 2 diabetes who take Ozempic are at increased risk of developing damage to the optic nerve, leading to severe and permanent loss of vision. The risk doubles compared to those not taking Ozempic.
SourceUniversity of Southern Denmark Faculty of Health Sciences·JournalInternational Journal of Retina and Vitreous·TypeData/statistical analysis·DateDec 16, 2024
Ocular immune-related diseases, including uveitis, diabetic retinopathy, age-related macular degeneration, and Graves' ophthalmopathy, are caused by abnormal immune inflammatory responses. The review highlights the role of microglia and other macrophages in these conditions, providing new target cells for prevention and treatment.
SourceSichuan International Medical Exchange and Promotion Association·JournalMedComm·DateDec 16, 2024
Apple iPhone 17 Pro
Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.
A new study published in Lancet Gastroenterology and Hepatology found that a combined screening approach can detect liver damage in people with type 2 diabetes. The method involves elastography, an ultrasound-based technique, which was found to be willing to be adopted by most patients. Early detection of liver fibrosis is crucial, as ...
SourceKarolinska Institutet·JournalThe Lancet Gastroenterology & Hepatology·DateDec 12, 2024
A research team led by USC aims to create comprehensive maps of retinal nerve connections to understand and combat retinitis pigmentosa, a progressive eye disease affecting 2 million people globally.
The University of Colorado Anschutz Medical Campus is developing a groundbreaking treatment for total blindness using whole eye transplantation. The $46 million award from ARPA-H will support research aimed at restoring vision to patients with total blindness.
SourceUniversity of Colorado Anschutz Medical Campus·DateDec 2, 2024
Researchers at Mass Eye and Ear developed an mRNA-based therapy to prevent scarring and blindness in PVR. The treatment, called RUNX1-Trap, targets a protein that regulates scar tissue formation, showing early promise for treating this eye disease.
SourceMass Eye and Ear·JournalScience Translational Medicine·TypeExperimental study·DateNov 27, 2024
Researchers have discovered two human antibodies that can recognize and target proteins causing severe malaria. These broadly reactive antibodies may represent a common mechanism of acquired immunity to severe malaria, offering insights for the design of a PfEMP1-based vaccine or treatment targeting severe malaria. The breakthrough cou...
SourceEuropean Molecular Biology Laboratory·JournalNature·DateNov 20, 2024
Davis Instruments Vantage Pro2 Weather Station
Davis Instruments Vantage Pro2 Weather Station offers research-grade local weather data for networked stations, campuses, and community observatories.
A phase 3 clinical trial has demonstrated that inebilizumab significantly reduced the risk of symptoms in patients with immunoglobulin G4-related disease (IgG4-RD) by 87%. The treatment, which depletes CD19-expressing B cells, shows promise for improving patient outcomes and reducing the need for immunosuppressive treatment.
SourceMass General Brigham·JournalNew England Journal of Medicine·DateNov 14, 2024
A team of researchers has identified a mechanism that interferes with the splicing process in a more subtle way, leading to cell death. The study reveals that spliceosome subunits U4, U5, and U6 are normally stabilized by protein USP39, but when mutated or absent, stability is compromised, causing incorrect connections during splicing.
SourceGoethe University Frankfurt·JournalScience·TypeExperimental study·DateNov 14, 2024
A new scientific statement highlights improvements in diagnosis, initial treatment, and long-term management of patients with Kawasaki Disease, emphasizing the need for tailored management strategies. Advances in cardiac imaging techniques and risk categorization have led to better patient outcomes.
SourceAmerican Heart Association·JournalCirculation·DateNov 13, 2024
Researchers from Indiana University have uncovered how the EphA2 protein receptor contributes to cataract formation. The study found that canonical ligand-dependent EphA2 signaling remains stable in aging lens tissue, while non-canonical signaling increases with age, affecting lens fiber cell maturation.
SourceImpact Journals LLC·JournalAging-US·TypeNews article·DateNov 13, 2024
SAMSUNG T9 Portable SSD 2TB
SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.
A study reveals racial disparities in genetic detection rates for inherited retinal diseases, with lower rates observed in Black patients compared to white patients. The findings highlight the need for improved genetic testing and therapeutic development to address these disparities.
SourceJAMA Network·JournalJAMA Ophthalmology·DateNov 7, 2024
Researchers have identified a new experimental drug that can bridge the gap between patients with wet age-related macular degeneration (AMD) and existing treatments. The drug, 32-134D, decreases levels of a key protein involved in AMD, leading to improved vision outcomes.
SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateNov 4, 2024
Researchers at Rensselaer Polytechnic Institute have developed a novel compound to treat dry age-related macular degeneration and Stargardt disease, both blindness-causing diseases. The compound has shown therapeutic potential in slowing down disease progression and preserving vision.
A new study found that long-term, low-dose valacyclovir treatment significantly reduces the risk of vision-damaging bouts of inflammation and infection in patients with shingles. Participants treated for a year saw a 26% reduction in eye disease flare-ups at 18 months.
SourceNYU Langone Health / NYU Grossman School of Medicine·TypeRandomized controlled/clinical trial·DateOct 19, 2024
Meta Quest 3 512GB
Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.
Researchers found that using valacyclovir for a year can decrease the risk of new or worsening eye disease and prevent vision loss associated with shingles. The study, which enrolled over 500 participants, showed that this treatment reduced the risk of complications by 30%.
SourceUniversity of Pennsylvania School of Medicine·DateOct 19, 2024
Researchers have identified shared critical pathways in retinitis pigmentosa disease models using advanced proteomics techniques. This study suggests that disease-modifying treatments could benefit patients with all forms of the disease, regardless of the underlying mutation.
SourceUniversity of Eastern Finland·JournalMolecular & Cellular Proteomics·DateOct 16, 2024
Researchers have successfully transplanted human embryonic stem cell-derived retinal organoid sheets into monkeys with macular holes, resulting in graft survival and maturation of light-detecting cells. The study suggests that this method could become a practical treatment option for difficult macular hole cases.
SourceCell Press·JournalStem Cell Reports·TypeExperimental study·DateOct 3, 2024
AmScope B120C-5M Compound Microscope
AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.
Researchers at Arizona State University have developed new diagnostic tools using artificial intelligence (AI) to help identify myopic maculopathy, a serious eye condition. The AI-powered systems can analyze retinal images and predict the correct classification of the disease, enabling more accurate treatment recommendations.
SourceArizona State University·JournalJAMA Ophthalmology·TypeNews article·DateOct 2, 2024
Researchers identified a crucial protein, TIMP3, overproduced in AMD and found that blocking its activity can reduce drusen formation, suggesting a promising treatment strategy. The study offers new avenues for preventing AMD and improving the lives of millions affected by this disease.
SourceUniversity of Rochester Medical Center·JournalDevelopmental Cell·DateOct 2, 2024
Researchers have discovered a gene responsible for some inherited retinal diseases, which damage the retina and threaten vision. The study identified the UBAP1L gene as a cause of different forms of retinal dystrophy, including maculopathy and cone-rod dystrophy, affecting central and night vision.
SourceNIH/National Eye Institute·JournalJAMA Ophthalmology·TypeCase study·DateSep 26, 2024
A UD researcher has received a $2.3M NIH grant to investigate inherited retinal diseases. The funding will support groundbreaking research that could lead to significant breakthroughs in understanding and addressing these conditions.
DJI Air 3 (RC-N2)
DJI Air 3 (RC-N2) captures 4K mapping passes and environmental surveys with dual cameras, long flight time, and omnidirectional obstacle sensing.
Researchers at UCL Institute of Ophthalmology have revealed the molecular mechanisms behind FECD, a leading cause of vision loss in older adults. The study found that extreme genetic instability plays a key role in the disease's progression.
SourceUniversity College London·JournalEBioMedicine·DateSep 19, 2024
A University of Houston team developed non-invasive, comfortable, and safe wearable sensors to monitor eyeball movements, providing early warning signs of brain-related disorders. The new sensors have potential applications in diagnosing conditions like ADHD, autism, Alzheimer's disease, Parkinson's disease, and traumatic brain injuries.
SourceUniversity of Houston·JournalAdvanced Healthcare Materials·DateSep 16, 2024
Researchers have introduced DSFN to improve the speed and accuracy of diagnoses of retinal disorders. This AI-powered medical imaging technique combines retina images with vascular distribution information to accurately locate the fovea in complex clinical scenarios, enabling doctors to detect early signs of ocular diseases.
SourceXi'an Jiaotong-Liverpool University·JournalIEEE Journal of Biomedical and Health Informatics·TypeComputational simulation/modeling·DateSep 12, 2024
Aranet4 Home CO2 Monitor
Aranet4 Home CO2 Monitor tracks ventilation quality in labs, classrooms, and conference rooms with long battery life and clear e-ink readouts.
Researchers aim to find a new treatment pathway for diabetic retinopathy by targeting the IL-6 protein. They suspect that selectively inhibiting trans-signaling while allowing cis-signaling will stop damage and restore balance in the retina.
SourceMedical College of Georgia at Augusta University·DateSep 12, 2024
Researchers found that laughter exercise improved dry eye disease symptoms and clinical signs, such as ocular surface discomfort and tear break-up time, comparable to eye drops. Laughter therapy also showed benefits in mental health scores.
SourceBMJ Group·JournalThe BMJ·TypeRandomized controlled/clinical trial·DateSep 11, 2024
A Danish study published in The Journal of Dental Research found that individuals with diabetes complications are at higher risk of gum disease. Periodontitis was more common among those with microvascular complications such as retinopathy and neuropathy.
SourceDiabetologia·JournalJournal of Dental Research·DateSep 10, 2024
Researchers at Karolinska Institutet successfully used gene therapy to improve vision in 11 out of 12 patients with Bothnia dystrophy, a form of hereditary blindness. The treatment involved injecting a specially designed virus under the retina, which produced normal protein and restored visual function.
SourceKarolinska Institutet·JournalNature Communications·DateSep 10, 2024
GoPro HERO13 Black
GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.
Researchers developed a gene therapy that restored useful vision to most patients with Leber congenital amaurosis type I, a rare inherited blindness. The treatment showed a 10,000-fold improvement in light sensitivity and improved navigation abilities in patients who received the highest dose.
SourceUniversity of Florida·JournalThe Lancet·TypeRandomized controlled/clinical trial·DateSep 5, 2024
A Phase 1/2 clinical trial found significant vision improvements in patients with Leber congenital amaurosis, a rare inherited condition causing early childhood blindness. The gene therapy, ATSN-101, demonstrated efficacy in correcting genetic mutations and restoring vision for up to 12 months.
SourceUniversity of Pennsylvania School of Medicine·JournalThe Lancet·DateSep 5, 2024
A clinical trial led by UC San Francisco aims to develop new therapies for progressive supranuclear palsy, with a focus on reducing time to find effective treatments and increasing diverse participant enrollment. The five-year grant could lead to the first effective drugs for this incurable neurodegenerative disorder.
SourceUniversity of California - San Francisco·DateSep 3, 2024
Sky & Telescope Pocket Sky Atlas, 2nd Edition
Sky & Telescope Pocket Sky Atlas, 2nd Edition is a durable star atlas for planning sessions, identifying targets, and teaching celestial navigation.
A new imaging device that combines optical coherence tomography (OCT) with traditional otoscopy improves diagnostic capabilities for hearing clinics. The integrated device provides detailed views of the eardrum and middle ear, enabling more accurate diagnoses and treatment.
SourceSPIE--International Society for Optics and Photonics·JournalJournal of Biomedical Optics·DateAug 23, 2024
Scientists at the University of Augsburg have found that macrophages, also known as scavenger cells, form in the vitreous body of the mouse eye during embryonic development. This new understanding could lead to therapies for diseases like diabetic retinopathy and prenatal vessel defects.
SourceUniversity of Augsburg·JournalJournal of Neuroinflammation·TypeExperimental study·DateAug 19, 2024
Researchers found that children's immune systems attacked their own tissues after latching onto a coronavirus protein resembling one found in multiple organs. Early intervention was crucial to prevent death in these cases, and the study has implications for understanding other autoimmune diseases.
SourceUniversity of California - San Francisco·JournalNature·DateAug 7, 2024
Kestrel 3000 Pocket Weather Meter
Kestrel 3000 Pocket Weather Meter measures wind, temperature, and humidity in real time for site assessments, aviation checks, and safety briefings.
A recent study published in JAMA Network Open demonstrated the effectiveness of AI in detecting myopia, strabismus, and ptosis using smartphone images. This technology has the potential to facilitate early detection of pediatric eye diseases in a convenient and accessible manner.
SourceJAMA Network·JournalJAMA Network Open·DateAug 6, 2024
A study funded by the National Eye Institute found that 6.5 million Medicaid enrollees lacked routine adult eye exam coverage, while 14.6 million had no eyeglasses coverage. State-level variation in coverage policies and copays hindered access to essential eye care services.
SourceNIH/National Eye Institute·JournalHealth Affairs·TypeData/statistical analysis·DateAug 6, 2024
Researchers genetically engineered Toxoplasma gondii to produce and release therapeutic proteins in the human brain, bypassing the blood-brain barrier. The method has potential implications for treating diseases caused by protein deficiencies or abnormal expression.
SourceTel-Aviv University·JournalNature Microbiology·DateAug 4, 2024
Researchers study T cells and monocytes interaction in the meninges before they attack the brain and spinal cord, potentially leading to new disease progression targets. The findings could provide a pathway to treating other neurological diseases like Alzheimer's and Parkinson's.
Researchers developed a preclinical model that shows knocking out VPS35 leads to alpha-synuclein aggregate accumulation, similar to human Parkinson's. The study also discovered a potential new strategy for detecting the disease using autofluorescence technology.
SourceWeill Cornell Medicine·JournalNature Communications·DateJul 23, 2024
Sky-Watcher EQ6-R Pro Equatorial Mount
Sky-Watcher EQ6-R Pro Equatorial Mount provides precise tracking capacity for deep-sky imaging rigs during long astrophotography sessions.
A combination treatment incorporating three drugs – tamsulosin, metoprolol, and bromocriptine – significantly slowed disease progression in four different animal models of IRD. The study suggests that drug repurposing could provide solutions for rare diseases like retinal degenerations, which are currently inaccessible therapeutically.
SourceUniversity of Eastern Finland·JournalNature Communications·DateJul 22, 2024
A new genetic test has identified a mutation causing progressive retinal atrophy (PRA) in English Shepherd Dogs, allowing breeders to eliminate the disease from their population. The test is available for purchase and will help prevent the disease from being passed on to puppies.
SourceUniversity of Cambridge·JournalGenes·TypeExperimental study·DateJul 21, 2024
Researchers at UCL and Moorfields Eye Hospital have identified biomarkers that predict which patients with glaucoma are at higher risk of continued vision loss despite conventional treatment. Mitochondrial function in white blood cells is lower in people with glaucoma, leading to faster vision loss.
SourceUniversity College London·JournalNature Medicine·TypeRandomized controlled/clinical trial·DateJul 12, 2024
Celestron NexStar 8SE Computerized Telescope
Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.
A study found that both short and long sleep durations are associated with a higher risk of microvascular disease in individuals recently diagnosed with type 2 diabetes. Short sleep duration, especially among older adults, was linked to a significantly increased risk of blood vessel damage.
Researchers have identified early changes in AMD patients that lead to measurable local vision loss. The study's findings could help improve treatment and monitoring of the disease, enabling new therapies and improved treatments for central blindness.
SourceUniversitatsklinikum Bonn·JournalBMJ Open Ophthalmology·DateJul 9, 2024
Researchers discuss the critical role of the retinal pigmented epithelium in human vision and its susceptibility to aging. The study highlights the importance of understanding molecular and cellular mechanisms driving age-related pathological changes in vision decline.
SourceImpact Journals LLC·JournalAging-US·TypeCommentary/editorial·DateJul 9, 2024
Researchers at Case Western Reserve University will test a possible breakthrough drug for inherited retinal disease, which may prevent blindness in patients with various genetic mutations. The study aims to advance the technology to FDA-regulated clinical trials and potentially expand the application of the Bax-inhibiting therapeutic.
Sony Alpha a7 IV (Body Only)
Sony Alpha a7 IV (Body Only) delivers reliable low-light performance and rugged build for astrophotography, lab documentation, and field expeditions.
Scientists have mapped over 5,000 genetic variants in the 'tumour protection' gene BAP1 that significantly increase cancer risk. These variants can be used to develop new treatments, including IGF-1 inhibitors, to slow down or prevent cancer progression.
SourceWellcome Trust Sanger Institute·JournalNature Genetics·TypeExperimental study·DateJul 5, 2024
A new study found that patients prescribed semaglutide for diabetes or weight loss have a higher risk of developing NAION, a potentially blinding eye condition. The study revealed a significant risk increase in diabetic and overweight/obesity patients taking semaglutide.
SourceMass Eye and Ear·JournalJAMA Ophthalmology·TypeObservational study·DateJul 3, 2024
The article reviews recent advances in applying artificial intelligence to oncology, showcasing promising improvements in cancer care. The authors emphasize the need for interdisciplinary collaboration, rigorous validation, and ethical principles to harness AI's potential.
SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalAI in Precision Oncology·TypeSystematic review·DateJun 28, 2024
Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C)
Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C) keeps Macs, tablets, and meters powered during extended observing runs and remote surveys.
A new photodynamic therapy method has been shown to effectively eradicate ocular melanoma in mice, with the technique delivering two photons and minimizing damage to healthy tissue. The approach offers a promising alternative to current treatments that are often ineffective or invasive.
SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournalProceedings of the National Academy of Sciences·DateJun 27, 2024
A new AI model has been developed to improve clinical trial recruitment for eye disease, specifically Geographic Atrophy. The system identified almost twice as many candidates and with higher precision compared to conventional approaches, showing promise for overcoming a major obstacle in GA clinical trials.
SourceUniversity College London·JournalOphthalmology Science·TypeComputational simulation/modeling·DateJun 25, 2024
Researchers have developed a new treatment for diabetic retinopathy that addresses the root cause of the disease, preventing progression and potential blindness. The anti-ceramide immunotherapy has been shown to be effective in animal and cell culture models, offering a safer alternative to current treatments.
SourceUniversity of Oklahoma·JournalCell Metabolism·TypeExperimental study·DateJun 17, 2024
CalDigit TS4 Thunderbolt 4 Dock
CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.
Researchers find that a repurposed drug, crizanlizumab, stabilizes vision in patients with retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) after two years of treatment. The study suggests that this may give patients additional years to read, drive, and enjoy activities.
SourceWashU Medicine·JournalJournal of Clinical Investigation·TypeRandomized controlled/clinical trial·DateJun 17, 2024
Researchers found that mono-canalicular Lacrijet stent insertion is a safe and effective treatment for congenital nasolacrimal duct obstruction in children, with success rates unaffected by age or previous failed probing. The study suggests early assessments and stenting as an option for pediatric epiphora management.
SourceBentham Science Publishers·JournalThe Open Ophthalmology Journal·DateJun 13, 2024
Researchers developed a custom-built robot system to treat wet neovascular age-related macular degeneration (AMD), administering radiation followed by injections. The treatment reduced the number of injections needed by about a quarter, potentially saving around 1.8 million injections per year worldwide.
SourceKing's College London·JournalThe Lancet·DateJun 11, 2024
A study analyzing pooled clinical trial data found that teprotumumab maintained improvements in signs and symptoms of thyroid eye disease in most patients after 51 weeks. Nearly two years after the final infusion, 82% of patients did not require further treatment.
SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalThyroid·TypeNews article·DateJun 8, 2024
Apple Watch Series 11 (GPS, 46mm)
Apple Watch Series 11 (GPS, 46mm) tracks health metrics and safety alerts during long observing sessions, fieldwork, and remote expeditions.
Researchers developed DiFC, a two-color diffuse flow cytometry system that detects rare cancer cells in the bloodstream without invasive methods. The technology provides insights into cancer progression and response to treatments by studying different subpopulations of cancer cells simultaneously.
SourceSPIE--International Society for Optics and Photonics·JournalJournal of Biomedical Optics·DateJun 7, 2024
A team of scientists developed a method to quickly measure the frequency characteristics of photoreceptors' response to flicker stimulation, allowing for faster diagnosis of visual disorders. The new technique, called f-ORG, reduces the time required to conduct experiments and analyze data.
SourceInstitute of Physical Chemistry of the Polish Academy of Sciences·JournalOptics Letters·DateJun 6, 2024
A study found that patients with thyroid eye disease who received teprotumumab infusions maintained efficacy 51 weeks after treatment. Nearly two years later, 82% of patients did not require additional treatment for their condition.
SourceThe Endocrine Society·JournalThyroid·DateJun 2, 2024